Introduction
Hepatocellular carcinoma (HCC) is the fifth most common type of malignancy worldwide and is the third leading cause of cancer-associated mortality worldwide (1) . The majority of patients with HCC are diagnosed when the disease is at an advanced stage, and potentially curative therapeutic options for HCC are limited (2) . Thus, there is an urgent need to identify and establish alternative approaches for the treatment of HCC. Immunotherapy has gained attention in previous years as a promising adjuvant therapy for HCC patients. A complex role of the immune system in the development and progression of HCC has been highlighted by a growing number of studies (3) (4) (5) . To improve the clinical efficacy of cancer immunotherapy, a detailed understanding of the immunological mechanism of tumorigenesis and progression is required.
The tumor microenvironment is a systematic concept that defines the behavior of cancer not only by the genetics of the tumor cells alone but also by the surrounding milieu. Tumor infiltrating lymphocytes (TILs), an important part of the tumor surveillance system, have been detected in a number of patients with HCC. In particular, cluster of differentiation (CD) 8 + cytotoxic T lymphocytes (CTLs) were found to be linked to an improved patient survival (6, 7) . However, the spontaneous clearance of established HCC lesions by endogenous immune mechanisms is rare, despite spontaneous humoral and cellular immune responses having been detected in a significant proportion of patients with HCC against a number of tumor-associated antigens (TAAs) (8) (9) (10) . As a number of TAAs are derived from normal self-constituents, anti-tumor immunity against these TAAs was not sufficient to control the growth of the tumors. Additionally, in the pressure of a host immune system, HCC has evolved multiple passive and active mechanisms that generate a suppressive network in order to evade the host's anti-tumor immune response (11, 12) . Such mechanisms include an accumulation of immunosuppression by regulatory T cells (Tregs), tumor-associated macrophages and dysfunctional dendritic cells (DC) (13) (14) (15) . Tregs are the most extensively studied mechanism, and an increased frequency of Tregs in the peripheral blood and tumor tissues of HCC has been studied previously (16, 17) . Furthermore, the upregulation of Tregs is notably coupled with a significant decrease and impaired effector function of cytotoxic CD8 + T cells, and a worse predicted survival rate for patients with HCC (18, 19) . However, cells with a potential suppressive function against anti-tumor immunity are not confined to this cell subset. Regulatory γδ T cells and natural killer (NK) T cells had been gradually identified as having a potential suppressive function by several studies (20) (21) (22) . The distribution of forkhead box P3 (FOXP3) + cells in various cell subsets of HCC has been presented in our previous study (23) .
The range of lymphocytes present in the liver differs markedly from that in the peripheral blood and other organs (24) (25) (26) . Lymphocytes in the liver are characterized by a high proportion of NK cells and significant numbers of several unconventional T cell subsets, such as T cells that co-express CD3 and CD56, which can also be referred to as natural T cells (27) . Considering the high prevalence of NK and natural T cells in the liver, it is suggested that they perform a critical role in immune homeostasis and pathogenesis of the liver. The present study was interested in the implication of NK and natural T cells in the pathology of HCC. As reported by Kawarabayashi et al (28) a decreased abundance of NK cells and natural T cells in liver diseases may be involved in their susceptibility to HCC. Therefore, the principal objective of the present study was to determine the representation of NK cells and natural T cells in local tumor tissues and in peripheral blood of patients with HCC. The present study observed a marked reduction in NK cells and natural T cells in TILs vs. non-tumor infiltrating lymphocytes (NILs). However, this pattern was not observed in peripheral blood mononuclear cells (PBMCs) of patients with HCC vs. healthy donors. In addition, a new type of FOXP3-expressing natural T cell was identified in the tumorous tissues of HCC, and several phenotypic and functional tests were then performed on this special cell subset. It is considered that this discovery may provide a new mechanistic explanation for HCC induced immunosuppression, and outline a previously unrecognized potential target for the immunotherapy of HCC.
Materials and methods
Patients and healthy donors. This study was approved by the hospital ethics review committee at the Peking University People's Hospital (Beijing, China), and written informed consent was obtained from all patients prior to the start of the study. A total of 16 paired tumorous and adjacent non-tumorous tissue samples were collected from patients with HCC at the time of surgery. Surgery was performed at the Center of Hepatobiliary Surgery, Tianjin Medical University Cancer Institute and Hospital (Tianjin, China). Blood samples from 11 of these patients were also collected, and blood samples from 11 healthy volunteers were obtained from the blood bank of Beijing Red Cross to use as controls. HCC was diagnosed according to the diagnostic guidelines of the European Association for the Study of the Liver (Geneva, Switzerland). Patient characteristics and demographic data are shown in Table I .
Cell isolation and purification. Tumorous and non-tumorous (>5 cm from the tumor margin) tissue infiltrating lymphocytes (TILs and NILs) were obtained using a method based on mechanical dissociation and collagenase treatment as described previously (23 Statistical analysis. Data are presented as the mean ± standard error of the mean for percentages. The significance of the difference between group means was determined using the Student's t-test by using GraphPad Prism (version5.0; GraphPad Software, Inc., La Jolla, CA, USA). P<0.05 was considered to indicate a statistically significant difference.
Results

Reduced natural T and NK cells in TILs of patients with HCC.
Considering the abundance of natural T cells and NK cells in the human liver, it was necessary to investigate the representation of natural T cells and NK cells in local tumor tissues of human HCC. TILs and NILs were obtained as described previously (23) . Flow cytometry was then performed on a total of 16 paired TILs and NILs using fluorescence labeled monoclonal antibodies specific for CD3 and CD56. The percentages of natural T cells (6.315±1.002 vs. 17.16±1.804, P<0.001) and NK cells (6.324±1.559 vs. 14.52±2.336, P<0.01) were markedly reduced in TILs compared with that in NILs, as determined by flow cytometry analysis (Fig. 1) . Fig. 2A + cell subset in autologous natural T cell and conventional T cell populations in TILs, which suggested that there was no association between the level of FOXP3 and CD56 expression. By contrast, dot plots in Fig. 3 showed a positive association between the level of FOXP3 expression and forward scatter/side scatter gating in natural T cells.
Identification of FOXP3 + natural T cells in TILs of patients with HCC. As shown in
Representation of natural T cells and NK cells in PBMCs of patients with HCC.
In contrast with what was found in the local tumor tissues, there was no clear change in the percentages of natural T cells (Fig. 4A, P>0 .05) and NK cells (Fig. 4B, P>0 .05) in the peripheral blood from patients with HCC in comparison with that from healthy donors. In addition, the prevalence of FOXP3 + cells was not observed in natural T cell populations in the peripheral blood of patients with HCC, despite a significant accumulation of FOXP3 + cells in autologous conventional T cell population in TILs having been detected at the same time (Fig. 4C, P<0 .001). One unique characteristic of resident human hepatic lymphocytes is a reversed CD4/CD8 ratio (1:3.5) compared with that in PBMCs (2:1) (24). The present study found the percentage of CD4 + cells to be observably higher in the natural T cell subset (Fig. 4D, P<0 .01) and the conventional T cell subset (Fig. 4E, P<0 .05) in TILs than in NILs. Conversely, the percentage of the CD8 + cell subset was markedly reduced in TILs compared with NILs (Fig. 4D, P<0.05; Fig. 4E , P<0.01). Nevertheless, there were no notable changes in the percentages of the CD4 + cell population and the CD8 + cell population in the natural T cell subset and the conventional T cell subset when referring to the PBMCs from patients with HCC in comparison with that from healthy donors (Fig. 4F,  P>0 .05).
Phenotypic and functional characterization of FOXP3
+ natural T cells in TILs. Similar to conventional Tregs, the majority of the FOXP3 + cell population in natural T cells exhibited positive expression of CD25 and CTLA-4 (Fig. 5A) .
IFN-γ and perforin are important effector molecules for natural T cells. TILs and NILs were stimulated with PMA (50 ng/ml) and ionomycine (1 µg/ml) for 4 h, respectively, and subsequently examined for the expression of IFN-γ and perforin in natural T cells in the context of FOXP3 expression by flow cytometry. The present results demonstrate that the acquisition of FOXP3 appeared to be accompanied with the loss of expression of IFN-γ and perforin, due to the mutually exclusive expression between IFN-γ and perforin and FOXP3 as shown in the dot plots ( Fig. 5B and C) . (Fig. 6) . 
Immunosuppressive function of FOXP3 + natural T cells in
Discussion
A number of studies have documented HCC progress in the presence of tumor-specific immune responses in a majority of patients with HCC, indicating that HCC has evolved multiple mechanisms to evade host anti-tumor immunity (3) (4) (5) 11, 12) . To improve the efficacy of immunotherapy for HCC, it is critical to improve understanding of the mechanisms behind this immune suppression.
Although it is well established that reduced CD8 + CTLs and increased FOXP3 + cells in HCC are coupled with poor prognosis (18, 19) , it is now also being recognized that the innate arm of the immune system may also perform a potentially important role in immune responses in liver diseases (25, (28) (29) (30) (31) (32) . Suppressive innate immunocytes including regulatory DCs, γδ T cells and NKT cells have gained attention in previous years (15, (20) (21) (22) . The present study describes a different representation of natural T cells and NK cells between TILs and peripheral lymphocytes of human HCC. Natural T cells and NK cells were markedly decreased in TILs vs. NILs, whilst the proportions were not altered in PBMCs from patients with HCC in comparison with that from healthy donors. By contrast, several studies have indicated a reduction in the proportion of NK cells in vPBMCs from patients with HCC (33, 34) . Conversely, a previous investigation from 28 patients with HCC in tumor node metastasis stage I demonstrated that the proportion of NK cells in PBMCs did not differ from the proportion of NK cells in PBMCs from healthy controls (35) . These conflicting studies may be in part due to the relatively low proportion of NK cells in PBMCs of the included healthy donors in the present study.
The -) in TILs. These results however suggested that there is no significant correlation between these factors. The mean proportion of FOXP3 expressing cells was higher in the natural T cell subset compared with that in the conventional T cell subset in TILs (Fig. 2B) . In individuals, the proportions of FOXP3 + cells in the natural T cell subset and in the conventional T cell subset in TILs were not always equivalent (Fig. 2C) . Regarding the PBMCs from patients with HCC, an unaltered representation of natural T cells and NK cells was observed in comparison with that from healthy donors, and a significant proportion of the FOXP3 + cell population only existed in the conventional T cell subset but not in the natural T cell subset. In NK cells, no FOXP3-expressing cells were detected in either TILs or PBMCs. In summary, it was identified that FOXP3 + natural T cells spontaneously existed in TILs of HCC as a new regulatory cell subset, which were mostly derived from natural T cells infiltrating in the local microenvironment of HCC but not recruited from the peripheral blood.
As studied, apart from conventional CD4 + FOXP3 + regulatory cells, CD8 + and T cell receptor (TCR) γδ + regulatory T cells have been identified in prostate and breast cancer, respectively (36, 37) . Although TCRγδ + and CD8 + cell populations were dominant in the natural T cell subset in the human liver, the identified FOXP3 + natural T cells in TILs of HCC were confined to TCRγδ -and CD8 -cell populations. In addition, the acquisition of FOXP3, appeared to be accompanied with the loss of classical functions of natural T cells, since the expression of FOXP3, IFN-γ and perforin in natural T cells was mutually exclusive on single cell level through the flow cytometric scatter plots graphs (Fig. 5B and C) . By contrast, granzyme B and perforin were found to be relevant for Tregs-mediated suppression of tumor clearance in vivo (38) .
FOXP3 is essential for the programming, development, differentiation and suppressive functioning of Tregs, and is a definitive marker for Tregs (39) . A number of studies have demonstrated that overexpression of FOXP3 in naïve T cells and/or T cell lines through lentiviral infection resulted in acquisition of suppressive activity (40) (41) (42) (43) (44) (45) . The authors of the present study speculate whether in vitro FOXP3-lentiviral infection is sufficient for the acquisition of immunosuppressive activity in natural T cells, and this will be investigated in further studies. Although there was a high percentage of natural T cells with FOXP3 + expression in TILs, the prevalence of FOXP3 + natural T cells in TILs was not as high as Tregs in TILs, due to a decrease in cell numbers in the overall natural T cell subset in TILs.
In conclusion, the identification of the unique FOXP3 + natural T cells may be helpful to improve understanding of the immunosuppressive local microenvironment in HCC, and it is hypothesized that it may also provide useful clues for the improvement of therapeutic intervention of HCC in the future.
